Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | The Biotech Growth Trust PLC (Ordinary Share) | +23.15% |
NAV | The Biotech Growth Trust PLC (Ordinary Share) | +18.88% |
Morningstar's Benchmark | NASDAQ Biotechnology TR GBP | -- |
- The Biotech Growth Trust Plc - Net Asset Value(s)
- The Biotech Growth Trust Plc - Transaction in Own Shares
- The Biotech Growth Trust Plc - Monthly Fact Sheet as at 31 March 2024
- The Biotech Growth Trust Plc - Total Voting Rights
- The Biotech Growth Trust Plc - Director/PDMR Shareholding
- The Biotech Growth Trust Plc - Monthly Fact Sheet as at 29 February 2024
- The Biotech Growth Trust Plc - Director Declaration
- The Biotech Growth Trust Plc - Blocklisting - Interim Review
- The Biotech Growth Trust Plc - Monthly Fact Sheet as at 31 January 2024
More ▼
Key statistics
On Thursday, The Biotech Growth Trust PLC (BIOG:LSE) closed at 926.00, -10.44% below its 52-week high of 1,034.00, set on Feb 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 33.49m |
---|---|
Market cap | 317.46m GBP |
Total assets | 388.05m GBP |
Total expense ratio | 1.08% |
High | 955.00 |
Low | 925.00 |
Previous close | 950.00 |
Average volume | 70.59k |
---|---|
YTD Change | +3.58% |
Beta | 0.6334 |
Diluted NAV (est) | 990.48 |
Diluted NAV (last pub) | 1,020.36 |
Premium/Discount | -6.51% |
Net Gearing | +9.66% |
Data delayed at least 20 minutes, as of Apr 25 2024 17:51 BST.
More ▼